Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Surgical treatment for cubital tunnel syndrome can be effective using clinical tests without electrodiagnostics.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A man developed skin issues from cancer medication, which improved with specific treatments.

Scalp cooling helps prevent hair loss during certain breast cancer treatments, especially when anthracyclines aren't used.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Some chemotherapy can cause permanent hair loss.

Cyclophosphamide likely causes skin darkening by affecting hair follicles.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

The combination treatment showed a higher response rate but no significant survival benefits.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.